[Antibiotic therapy of acute infection in patients with cancer].
Considerable progress has been made in the supportive care of patients undergoing cancer therapy. This progress has been associated with the improved survival of some patients. However, infection continues to be the major fatal complication in cancer. patients. The response of granulocytopenic patients with infections to some of the current available antibiotics is suboptimal. Since neutropenia is common during cancer treatment, there is a continual risk of infection in cancer patients; thus it is important for medical oncologists to become aware of these complications and their management. The most frequent types of acute infections, their clinical manifestations, and available antibiotic therapies were reviewed.
Fujimoto
T
T
D000212:Acyclovir / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications; D007951:Leukemia, Myeloid / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000188:drug therapy; D014740:Vidarabine / Q000008:administration & dosage; D014777:Virus Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D014740:Vidarabine; D000212:Acyclovir